Compare RFL & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RFL | NVX |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | Australia |
| Employees | N/A | 192 |
| Industry | Real Estate | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.6M | 95.9M |
| IPO Year | 2017 | N/A |
| Metric | RFL | NVX |
|---|---|---|
| Price | $3.16 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 294.9K | ★ 421.1K |
| Earning Date | 06-10-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $917,000.00 | N/A |
| Revenue This Year | N/A | $3,904.19 |
| Revenue Next Year | N/A | $91.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $1.12 | $0.43 |
| 52 Week High | $2.95 | $3.86 |
| Indicator | RFL | NVX |
|---|---|---|
| Relative Strength Index (RSI) | 80.07 | 29.75 |
| Support Level | $1.22 | N/A |
| Resistance Level | N/A | $0.74 |
| Average True Range (ATR) | 0.34 | 0.05 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 99.33 | 5.41 |
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.